TradingView
TheCryptoChartWhisperer
2022年3月10日午後10時5分

IFRX 1D Continued ロング

InflaRx N.V.NASDAQ

詳細

test
Just having some fun after a great ski trip to Breckenridge, Co for a couple of weeks. Let's get back into it.

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

トレード終了: 利益確定目標に到達

詳細